{"@context":"https:\/\/schema.org\/","@type":"Blog","@id":"https:\/\/www.regionalcancercare.org\/news\/#Blog","headline":"In the News","description":"","url":"https:\/\/www.regionalcancercare.org\/news\/","blogPost":[{"@type":"BlogPosting","@id":"https:\/\/www.regionalcancercare.org\/news\/speaking-at-national-conference-rcca-ceo-terrill-jordan-highlights-keys-to-success-of-new-medicare-cancer-services-reimbursement-model\/","headline":"Speaking at National Conference, RCCA CEO Terrill Jordan Highlights  Keys to Success of New Medicare Cancer Services Reimbursement Model","url":"https:\/\/www.regionalcancercare.org\/news\/speaking-at-national-conference-rcca-ceo-terrill-jordan-highlights-keys-to-success-of-new-medicare-cancer-services-reimbursement-model\/","datePublished":"2020-09-28","dateModified":"2021-11-11","mainEntityOfPage":"https:\/\/www.regionalcancercare.org\/news\/speaking-at-national-conference-rcca-ceo-terrill-jordan-highlights-keys-to-success-of-new-medicare-cancer-services-reimbursement-model\/","author":{"@type":"Person","@id":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/#Person","name":"ceastway","url":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/","identifier":5,"image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Regional Cancer Care Associates","logo":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","width":506,"height":228}},"image":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/Terrill-Jordan-Speaking.jpg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/Terrill-Jordan-Speaking.jpg","height":342,"width":598},"wordCount":718,"keywords":["News & Events"]},{"@type":"BlogPosting","@id":"https:\/\/www.regionalcancercare.org\/news\/chadwick-boseman-death-and-colon-cancer-in-younger-adults-black-americans\/","headline":"Chadwick Boseman death and colon cancer in younger adults, Black Americans","url":"https:\/\/www.regionalcancercare.org\/news\/chadwick-boseman-death-and-colon-cancer-in-younger-adults-black-americans\/","datePublished":"2020-09-16","dateModified":"2025-12-03","mainEntityOfPage":"https:\/\/www.regionalcancercare.org\/news\/chadwick-boseman-death-and-colon-cancer-in-younger-adults-black-americans\/","author":{"@type":"Person","@id":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/#Person","name":"ceastway","url":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/","identifier":5,"image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Regional Cancer Care Associates","logo":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","width":506,"height":228}},"image":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/Chadwick-Boseman-2-three.jpg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/Chadwick-Boseman-2-three.jpg","height":559,"width":670},"wordCount":1588,"keywords":null},{"@type":"BlogPosting","@id":"https:\/\/www.regionalcancercare.org\/news\/how-immunotherapy-targets-cancer-cells\/","headline":"How Immunotherapy Targets Cancer Cells","url":"https:\/\/www.regionalcancercare.org\/news\/how-immunotherapy-targets-cancer-cells\/","datePublished":"2020-08-15","dateModified":"2025-12-03","mainEntityOfPage":"https:\/\/www.regionalcancercare.org\/news\/how-immunotherapy-targets-cancer-cells\/","author":{"@type":"Person","@id":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/#Person","name":"ceastway","url":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/","identifier":5,"image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Regional Cancer Care Associates","logo":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","width":506,"height":228}},"image":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/RCCA-immunotherapy-targets-cancer-cells.jpg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/RCCA-immunotherapy-targets-cancer-cells.jpg","height":600,"width":900},"wordCount":703,"keywords":["Treatments","Immunotherapy","targeted therapy"]},{"@type":"BlogPosting","@id":"https:\/\/www.regionalcancercare.org\/news\/cancer-doesnt-wait\/","headline":"Cancer Doesn\u2019t Wait \u2013 And You Don\u2019t Need to Either: How RCCA  Is Treating Cancer While Guarding Patient Safety During the COVID-19 Crisis","url":"https:\/\/www.regionalcancercare.org\/news\/cancer-doesnt-wait\/","datePublished":"2020-07-07","dateModified":"2025-12-03","mainEntityOfPage":"https:\/\/www.regionalcancercare.org\/news\/cancer-doesnt-wait\/","author":{"@type":"Person","@id":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/#Person","name":"ceastway","url":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/","identifier":5,"image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Regional Cancer Care Associates","logo":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","width":506,"height":228}},"image":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/doctor-woman-mask-2.jpg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/doctor-woman-mask-2.jpg","height":470,"width":512},"wordCount":944,"keywords":["News & Events"]},{"@type":"BlogPosting","@id":"https:\/\/www.regionalcancercare.org\/news\/starting-chemotherapy-at-the-height-of-the-covid-19-outbreak-an-rcca-patients-story-and-message-to-others-with-cancer\/","headline":"Starting Chemotherapy at the Height of the COVID-19 Outbreak: An RCCA Patient\u2019s Story \u2013 and Message to Others with Cancer","url":"https:\/\/www.regionalcancercare.org\/news\/starting-chemotherapy-at-the-height-of-the-covid-19-outbreak-an-rcca-patients-story-and-message-to-others-with-cancer\/","datePublished":"2020-06-25","dateModified":"2025-12-03","mainEntityOfPage":"https:\/\/www.regionalcancercare.org\/news\/starting-chemotherapy-at-the-height-of-the-covid-19-outbreak-an-rcca-patients-story-and-message-to-others-with-cancer\/","author":{"@type":"Person","@id":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/#Person","name":"ceastway","url":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/","identifier":5,"image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Regional Cancer Care Associates","logo":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","width":506,"height":228}},"image":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/PANA5070.jpg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/PANA5070.jpg","height":2048,"width":1983},"wordCount":1242,"keywords":["Treatments","Chemotherapy","Infusion Therapy"]},{"@type":"BlogPosting","@id":"https:\/\/www.regionalcancercare.org\/news\/rcca-president-and-ceo-terrill-jordan-to-share-insights-at-patient-centered-oncology-care-conference-2020\/","headline":"RCCA President and CEO Terrill Jordan to Share Insights at Patient-Centered Oncology Care Conference 2020","url":"https:\/\/www.regionalcancercare.org\/news\/rcca-president-and-ceo-terrill-jordan-to-share-insights-at-patient-centered-oncology-care-conference-2020\/","datePublished":"2020-06-17","dateModified":"2021-11-11","mainEntityOfPage":"https:\/\/www.regionalcancercare.org\/news\/rcca-president-and-ceo-terrill-jordan-to-share-insights-at-patient-centered-oncology-care-conference-2020\/","author":{"@type":"Person","@id":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/#Person","name":"ceastway","url":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/","identifier":5,"image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Regional Cancer Care Associates","logo":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","width":506,"height":228}},"image":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/Terrill-Jordan.jpg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/Terrill-Jordan.jpg","height":900,"width":600},"wordCount":500,"keywords":["News & Events","Press Release"]},{"@type":"BlogPosting","@id":"https:\/\/www.regionalcancercare.org\/news\/important-announcement\/","headline":"Important Announcement","url":"https:\/\/www.regionalcancercare.org\/news\/important-announcement\/","datePublished":"2020-06-05","dateModified":"2023-04-06","mainEntityOfPage":"https:\/\/www.regionalcancercare.org\/news\/important-announcement\/","author":{"@type":"Person","@id":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/#Person","name":"ceastway","url":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/","identifier":5,"image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Regional Cancer Care Associates","logo":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","width":506,"height":228}},"image":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/09\/1111.jpg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/09\/1111.jpg","height":1000,"width":1000},"wordCount":104,"keywords":["News & Events"]},{"@type":"BlogPosting","@id":"https:\/\/www.regionalcancercare.org\/news\/cancer-and-covid-19-what-to-know\/","headline":"Cancer and COVID-19: What You Need To Know","url":"https:\/\/www.regionalcancercare.org\/news\/cancer-and-covid-19-what-to-know\/","datePublished":"2020-05-31","dateModified":"2021-11-11","mainEntityOfPage":"https:\/\/www.regionalcancercare.org\/news\/cancer-and-covid-19-what-to-know\/","author":{"@type":"Person","@id":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/#Person","name":"ceastway","url":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/","identifier":5,"image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Regional Cancer Care Associates","logo":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","width":506,"height":228}},"image":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/09\/Older-woman-wearing-face-mask.jpg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/09\/Older-woman-wearing-face-mask.jpg","height":600,"width":900},"wordCount":614,"keywords":["Patient Education"]},{"@type":"BlogPosting","@id":"https:\/\/www.regionalcancercare.org\/news\/cancers-most-likely-to-necessitate-targeted-monoclonal-immunotherapy\/","headline":"Cancers Most Likely To Benefit From Targeted Monoclonal Immunotherapy","url":"https:\/\/www.regionalcancercare.org\/news\/cancers-most-likely-to-necessitate-targeted-monoclonal-immunotherapy\/","datePublished":"2020-04-21","dateModified":"2025-12-03","mainEntityOfPage":"https:\/\/www.regionalcancercare.org\/news\/cancers-most-likely-to-necessitate-targeted-monoclonal-immunotherapy\/","author":{"@type":"Person","@id":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/#Person","name":"ceastway","url":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/","identifier":5,"image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Regional Cancer Care Associates","logo":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","width":506,"height":228}},"image":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/09\/Doctor-And-Patient-Talking.jpg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/09\/Doctor-And-Patient-Talking.jpg","height":600,"width":900},"wordCount":648,"keywords":["Treatments","Immunotherapy","targeted therapy"]}],"about":["Head and Neck Cancers","Melanoma","Stomach Cancer","Breast Cancer","Prostate Cancer","Colon Cancer","Lung Cancer","Lymphoma","Brain Cancer","Leukemia"]}